1. Home
  2. GLSI vs MPU Comparison

GLSI vs MPU Comparison

Compare GLSI & MPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLSI
  • MPU
  • Stock Information
  • Founded
  • GLSI 2006
  • MPU 1989
  • Country
  • GLSI United States
  • MPU Singapore
  • Employees
  • GLSI N/A
  • MPU N/A
  • Industry
  • GLSI Biotechnology: Pharmaceutical Preparations
  • MPU Transportation Services
  • Sector
  • GLSI Health Care
  • MPU Consumer Discretionary
  • Exchange
  • GLSI Nasdaq
  • MPU Nasdaq
  • Market Cap
  • GLSI 134.6M
  • MPU 129.2M
  • IPO Year
  • GLSI 2020
  • MPU 1998
  • Fundamental
  • Price
  • GLSI $11.65
  • MPU $2.61
  • Analyst Decision
  • GLSI Strong Buy
  • MPU
  • Analyst Count
  • GLSI 1
  • MPU 0
  • Target Price
  • GLSI $39.00
  • MPU N/A
  • AVG Volume (30 Days)
  • GLSI 45.8K
  • MPU 1.2M
  • Earning Date
  • GLSI 08-14-2025
  • MPU 09-09-2025
  • Dividend Yield
  • GLSI N/A
  • MPU N/A
  • EPS Growth
  • GLSI N/A
  • MPU N/A
  • EPS
  • GLSI N/A
  • MPU N/A
  • Revenue
  • GLSI N/A
  • MPU $35,228,600.00
  • Revenue This Year
  • GLSI N/A
  • MPU N/A
  • Revenue Next Year
  • GLSI N/A
  • MPU N/A
  • P/E Ratio
  • GLSI N/A
  • MPU N/A
  • Revenue Growth
  • GLSI N/A
  • MPU 305.32
  • 52 Week Low
  • GLSI $8.06
  • MPU $0.49
  • 52 Week High
  • GLSI $16.50
  • MPU $4.44
  • Technical
  • Relative Strength Index (RSI)
  • GLSI 53.04
  • MPU 50.35
  • Support Level
  • GLSI $11.51
  • MPU $2.10
  • Resistance Level
  • GLSI $12.07
  • MPU $2.93
  • Average True Range (ATR)
  • GLSI 0.58
  • MPU 0.50
  • MACD
  • GLSI -0.07
  • MPU -0.10
  • Stochastic Oscillator
  • GLSI 31.86
  • MPU 45.36

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.

About MPU Mega Matrix Corp.

Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.

Share on Social Networks: